Recruiting Psoriasis Studies in North New Hyde Park
About Psoriasis Clinical Trials in North New Hyde Park
Psoriasis is a chronic autoimmune skin condition affecting over 8 million Americans, causing cells to build up rapidly on the surface and forming red, scaly patches that can be itchy and painful. Plaque psoriasis accounts for about 80-90% of cases. While current treatments include topical therapies, phototherapy, and biologics like TNF inhibitors (adalimumab, etanercept) and IL-17/IL-23 inhibitors (secukinumab, guselkumab), clinical trials are testing next-generation oral treatments, TYK2 inhibitors, and combination approaches that may offer longer remission periods with fewer side effects. Patients with moderate-to-severe psoriasis who have not responded adequately to existing therapies are often sought for clinical trial enrollment.
There are currently 1 psoriasis clinical trials recruiting participants in North New Hyde Park, NEW%20YORK. These studies are seeking a combined 60 participants. Research is being sponsored by Bristol-Myers Squibb. Clinical trial participation is free and participants receive study-related medical care at no cost.
Psoriasis Clinical Trials in North New Hyde Park — FAQ
Are there psoriasis clinical trials in North New Hyde Park?
Yes, there are 1 psoriasis clinical trials currently recruiting in North New Hyde Park, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in North New Hyde Park?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the North New Hyde Park research site will contact you about next steps.
Are clinical trials in North New Hyde Park free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many North New Hyde Park studies also compensate for your time and travel.
What psoriasis treatments are being tested?
The 1 active trials in North New Hyde Park are testing new therapies including novel drugs, biologics, and treatment approaches for psoriasis.
Data updated March 2, 2026 from ClinicalTrials.gov